← Open Payments lookup

CAROL RUBEO: Open Payments

NPI 1184484537 · GREENWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,160 in 59 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $958 · 2025 $1,160

Food & beverage: $1,160
CompanyPaymentsAmount
ABBVIE INC.23$385
Alkermes, Inc.9$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$74
Otsuka America Pharmaceutical, Inc.2$55
Teva Pharmaceuticals USA, Inc.2$55
Janssen Pharmaceuticals, Inc2$54
Vanda Pharmaceuticals Inc.2$52
Biogen, Inc.2$50
Takeda Pharmaceuticals U.S.A., Inc.2$50
Otsuka Pharmaceutical Development & Commercialization, Inc.2$46

Products named: VRAYLAR, ARISTADA, REXULTI, CAPLYTA, ZURZUVAE, TRINTELLIX, COBENFY, FANAPT.

Industry payments across CT — which companies pay providers there.